Economic outcomes for the treatment of allergic rhinitis

PharmacoEconomics

Volumn 10, Issue 1, 1996, Pages 4-13

  Kozma, Chris M ^a   Sadik, M Kay ^a   Watrous, Marc L ^a  

^a UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; ANTIALLERGIC AGENT; ANTIHISTAMINIC AGENT; ASTEMIZOLE; CHLORPHENIRAMINE; CROMOGLYCATE DISODIUM; DECONGESTIVE AGENT; DIPHENHYDRAMINE; FLUTICASONE PROPIONATE; GLUCOCORTICOID; HYDROXYZINE; LORATADINE; PSEUDOEPHEDRINE; TERFENADINE;

ALLERGIC RHINITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; ECONOMIC ASPECT; HUMAN; IMMUNOTHERAPY; INTRANASAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REVIEW;

EID: 0029898135     PISSN: 11707690     EISSN: None     Source Type: Journal    
DOI: 10.2165/00019053-199610010-00002     Document Type: Review

References (42)

1. Young P. Asthma and allergies: an optimistic future. National Institutes of Health (NIH) publication no. 80-388. Bethesda (MD): US Department of Health and Human Services, NIH, 1980 Mar
2. Report of the NIAID task force on immunology and allergy. National Institutes of Health (NIH) publication no. 91-2414. Bethesda (MD): US Department of Health and Human Services, NIH, 1990 Sep
3. Naclerio RM. Allergic rhinitis. N Engl J Med 1991; 325 (12): 860-9
4. Rimpela AH, Savonius B, Rimpela MK, et al. Asthma and allergic rhinitis among Finnish adolescents in 1977-1991. Scand J Soc Med 1995; 23: 60-5
5. Magnussen H, Jorres R, Nowak D. Effect of air pollution on the prevalence of asthma and allergy: lessons from the German reunification. Thorax 1993; 48: 879-81
6. Sibbald B. Epidemiology of allergic rhinitis. Monogr Allergy 1993; 31: 61-79
7. Fleming DM, Crombie DL. Prevalence of asthma and hay fever in England and Wales. BMJ 1987 Jan 31; 294: 279-83
8. McMenamin P. Costs of hay fever in the United States in 1990. Ann Allergy 1994 Jul; 73: 35-9
9. Wilson JD, Braunwald E, Isselbacher KJ, et al., editors. Harrison's principles of internal medicine. New York: McGraw-Hill, 1991
10. Wood S. Allergic rhinitis and hayfever. Practitioner 1992 Apr; 236: 440-7
11. May JR. Allergic rhinitis. In: Dipiro JT, Talbert RL, Hayes PE, et al., editors. Pharmacotherapy: a pathophysiologic approach. New York: Elsevier, 1989: 945-53
12. Definition and classification of rhinitis. Allergy 1994; 19 Suppl. 19: 5-34
13. Drummond MF, Stoddart GL, Torrance GW. Methods for the evaluation of health care programmes. Oxford: Oxford University Press, 1987
14. Tarnasky PR, Van Arsdal Jr PP. Antihistamine therapy in allergic rhinitis. J Fam Pract 1990; 30 (1): 71-80
15. Assessing and treating rhinitis: a practical guide for Canadian physicians. Proceedings of the Canadian Rhinitis Symposium; 1994 Jan 14-15: Toronto. Can Med Assoc J 1994 Aug 15; 151 (4 Suppl.): 1-27
16. Dockhorn RJ, Bergner A, Connell JT, et al. Safety and efficacy of loratadine (Sch-29851): a new non-sedating antihistamine in seasonal allergic rhinitis. Ann Allergy 1987 Jun; 58: 407-11
17. Aaronson DW. Comparative efficacy of H1 antihistamines. Ann Allergy 1991 Nov; 67: 541-7
18. Prevost M, Turenne Y, Moote W, et al. Comparative study of SCH 434 and CTM-D in the treatment of seasonal allergic rhinitis. Clin Ther 1994; 16 (1): 50-6
19. Ziering RW, Klein GL. Allergic rhinitis. Postgrad Med 1991 Jan; 91 (1): 225-32
20. Juniper EF, Guyatt GH. Development of a new measure of health status for clinical trials in rhinoconjunctivitis. Clin Exp Allergy 1991; 21: 77-83
21. Juniper EF, Willms DG, Guyatt GH, et al. Aqueous beclomethasone dipropionate nasal spray in the treatment of seasonal (ragweed) rhinitis. Can Med Assoc J 1992 Sep 15; 147 (6): 887-92
22. Juniper EF, Guyatt GH, Archer B, et al. Aqueous beclomethasone dipropionate in the treatment of ragweed pollen-induced rhinitis: further exploration of 'as needed' use. J Allergy Clin Immunol 1993; 92: 66-72
23. Juniper EF, Guyatt GH, Dolovich J. Assessment of quality of life in adolescents with allergic rhinoconjunctivitis: development and testing of a questionnaire for clinical trials. J Allergy Clin Immunol 1994; 93: 413-23
24. Mackowiak JI. Fluticasone propionate aqueous nasal spray improves rhinitis quality of life and reduces lost labor costs [abstract]. Ann Allergy 1994; 72: 99A
25. Leickly F, Higgins D, Ownby D. A comparative cost-effectiveness study of two treatment modalities for ragweed hay fever [abstract]. J Allergy Clin Immunol 1987; 79: 189A
26. Berka C, Chin W. Fluticasone propionate intranasal steroid: cost-effectiveness vs antihistamines [abstract]. J Allergy Clin Immunol 1994 Jan; 93 (1 Pt 2): 165
27. Kozma CM, Schulz RM, Sclar DA. A comparison of costs and efficacy of fluticasone propionate aqueous nasal spray (FP) and terfenadine tablets [abstract]. Ann Allergy 1994 Jan; 72: 58
28. Medi-Span Inc. Medi-Span Prescription Pricing Guide. Indianapolis: Medi-Span Inc., 1993 Feb
29. Bootman JL, Townsend RJ, McGhan WF. Principles of pharmacoeconomics. Cincinnati: Harvey Whitney Books Company, 1991
30. McLemore T. National Ambulatory Medical Care Survey: 1985 summary. Hyattsville (MD): National Center for Health Statistics, 1987 Jun
31. International Classification of Diseases Clinical Modification. 9th rev. ed. Washington, DC: US Department of Health and Human Services, 1992
32. Kaliner M, Lemanske R. Rhinitis and asthma. JAMA 1992 Nov 25; 268 (20): 2807-29
33. Weeke ER. Epidemiology of hay fever and perennial allergic rhinitis. Monogr Allergy 1987; 21: 1-20
34. US Department of Health and Human Services. Asthma and allergy statistics. National Institute for Allergy and Infectious Diseases Statistics. Washington, DC: US Department of Health and Human Services, National Institutes of Health, 1995 May
35. US Department of Health and Human Services. National Center for Health Statistics Telephone Statistics (301-436-8500). Washington, DC: US Department of Health and Human Services, National Institutes of Health, 1995
36. Varney V. Hayfever in the United Kingdom. Clin Exp Allergy 1991; 21: 757-62
37. Vervloet D, van der Brempt X, Charpin D, et al. Immunotherapy in allergic respiratory diseases. Lung 1990; 168 Suppl.: 1013-24
38. Varney VA, Gaga M, Frew AJ, et al. Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by antiallergic drugs. BMJ 1991 Feb 2; 302: 265-9
39. Vuurman E, van Veggel L, Uiterwijk M, et al. Seasonal allergic rhinitis and antihistamine effects on children's learning. Ann Allergy 1993 Aug 17; 71: 121-6
40. Berman BA. Allergic rhinitis: mechanisms and management. J Allergy Clin Immunol 1988; 81: 980-4
41. Richards S, Thornhill D, Roberts H, et al. How many people think they have hay fever and what they do about it. Br J Gen Pract 1992 Jul; 42: 284-6
42. Bindslev-Jenson C. Antihistamines. In: Hvidberg EF, editor. Meyler's side effects of drugs. Amsterdam: Elsevier, 1992: 366-72